Key result
The combined use of guideline-recommended medications for ischaemic stroke increased significantly, with patients in 2014 having 1.89 times higher odds of receiving all three therapies compared to 2010.
Why the study?
Data on drug utilisation among stroke patients of Asian ethnicities were lacking.
Observational (n=4,935)
Yes
The study demonstrates a significant improvement in the utilization of guideline-directed medical therapies, including statins and antithrombotics, for secondary prevention in first-ever ischemic stroke patients in Singapore between 2010 and 2014.
Answers are grounded in this paper and cite their sources.
Supports improving secondary prevention adherence in ischaemic stroke; leaves open effects on recurrent events or mortality.
Introduction: Data on drug utilisation among stroke patients of Asian ethnicities are lacking. The objectives of the study were to examine the temporal trends and patient characteristics associated with prescription of thrombolytic, antithrombotic and statin medications among patients with first-ever stroke. Materials and Methods: First-ever ischaemic and haemorrhagic stroke patients admitted to 2 Singapore tertiary hospitals between 2010‒2014 were included. Data were extracted from the National Healthcare Group Chronic Disease Management System. Association between drug utilisation and admission year, as well as characteristics associated with drug use, were explored using multivariable logistic regression. Results: There was an increasing trend in the combined use of all 3 guideline medications in ischaemic stroke patients (P<0.001) ―specifically thrombolytic agents (P <0.001), oral antithrombotics (P = 0.002) and statins (P = 0.003) at discharge. Among antithrombotics, the use of clopidogrel (P <0.001) and aspirinclopidogrel (P <0.001) had increased, whereas prescription of dipyridamole (P <0.001) and aspirin-dipyridamole (P <0.001) had declined. For statins, the increase in atorvastatin prescription (P <0.001) was accompanied by decreasing use of simvastatin (P <0.001). Age, ethnicity and certain comorbidities (hyperlipidaemia, atrial fibrillation and chronic kidney disease) were associated with the combined use of all 3 guideline medications (P <0.05). In haemorrhagic stroke, prescription of statins at discharge were comparatively lower. Conclusion: This study reveals changes in prescription behaviour over time in a multiethnic Asian population with first-ever stroke. Patient characteristics including younger age, Malay ethnicity and certain comorbidities (i.e. hyperlipidaemia, atrial fibrillation) were associated with the combined use of all 3 guideline medications among ischaemic stroke patients.
No takes yet. Share an insight, caveat, or question.
Yeo et al. (2020) conducted an observational in First-ever ischaemic or haemorrhagic stroke (n=4,935). Admission year (2014 vs 2010) vs. Admission year 2010 was evaluated on Combined use of all 3 guideline medications (thrombolytic agents, antithrombotics, and statins) in ischaemic stroke (OR 1.89, 95% CI 1.23-2.89, p=<0.001). The combined use of guideline-recommended medications for ischaemic stroke increased significantly, with patients in 2014 having 1.89 times higher odds of receiving all three therapies compared to 2010.
Synapse has enriched 10 related papers. Consider them for comparative context: